Heart Failure, page-56

Yeah I'll have a go without going back to the recording. I think, according to my aging synapses that the question was aimed on the potential for other autoimmune diseases e.g. psoriatic athritis, and SI loved the question and replied about the real promise for applicability to to other disease states and how MSB's treatment for RA is really their most important application because of this potential. All very exciting. I just hope MSB doesn't fall at a hurdle with trying to be too tricky with their statistical analyses and use of measuring devices in their trials in a desparate attempt to attain the statistical significance so essential to prove the technology is not just safe "Disallowed". So far the jury is in on safety but out on efficacy. Not long now for the all important CHF interim stats which should begin to clear the debate up one way or the other.